%0 Journal Article
%T Interleukin-1¦Â provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma
%A Antonia Marazioti
%A Georgia A Giotopoulou
%A Georgios T. Stathopoulos
%A Giannoula Ntaliarda
%A Ioanna Giopanou
%A Ioannis Lilis
%A Magda Spella
%A Maria Oplopoiou
%A Sebastian Marwitz
%A Torsten Goldmann
%A Vasiliki Bravou
%A Vassilios Papaleonidopoulos
%J Archive of "Oncoimmunology".
%D 2019
%R 10.1080/2162402X.2019.1593802
%K Carboxypeptidase 3/mutation/IL
%K 1¦Â/lung cancer/urethane
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527299/